Other
73 N.Y.2d 487, 541 N.E.2d 562, 541 N.Y.S.2d 941 (1989)
Study notes for Hymowitz v. Eli Lilly: professor notes, cold call prep, exam angles, and memory aids.
Plaintiffs can recover damages from drug manufacturers under a market share liability theory even when the specific source of the harm is unknown.
Professor discussions around Hymowitz v. Eli Lilly will likely emphasize the landmark decision's implications for tort law, particularly the introduction of the market share liability theory. The ruling demonstrates a judicial recognition of the challenges injured plaintiffs face in cases involving toxic torts, where pinpointing the source of harm is often infeasible. This case serves as a crucial example of the courts' adaptability to ensure that the burden of proof does not rest unjustly on the injured parties, marking a pivotal shift in holding manufacturers accountable for harm caused by their products.
The case also opens the floor for discussions on equity and justice versus traditional standards of proof in tort law. By allowing plaintiffs to recover from manufacturers based on their market share of DES, the court acknowledges the collective responsibility of drug manufacturers, fostering a discourse on the ethical obligations of companies regarding public safety and health.
Market share means care: hold each maker fair!
| Case | Distinction |
|---|---|
| Bernhardt v. H.J. Heinz Co. | In Bernhardt, the plaintiffs could identify the specific manufacturer of the harmful product, which did not involve the complexities of market share liability. |
| Joint Tortfeasors Cases | Unlike traditional joint tortfeasor cases requiring proof of specific conduct, Hymowitz allows recovery without identifying a specific manufacturer. |
| Ramos v. Copeland | Ramos focused on causation under conventional tort principles; Hymowitz broke from this tradition by employing market share liability for situations where causation is ambiguous. |
The market share liability theory promotes justice for injured parties who may otherwise lack remedies, ensuring accountability from all contributing manufacturers.
Critics argue that market share liability could impose unfair burdens on manufacturers who may not be responsible for a specific harm, potentially leading to increased market costs.
This case is likely to appear on exams as a significant development in tort law, particularly around themes of liability and accountability in cases involving multiple defendants. Be prepared to discuss the implications of market share liability.